Looking to Partner with Companies Developing Small Molecule & Protein Degradation Therapeutics Across a Range of Undrugged or Hard-to-Drug Targets?
We partner with cutting-edge solution and service providers with small molecule specific capabilities in structural biology, medicinal chemistry, pre-clinical and clinical development, with the goal to assist the industry to overcome existing challenges to further progress in this emerging field to address unmet patient needs.
If you have relevant capabilities in this space and would like to align your brand with the small molecules and protein degradation community, contact us to promote your capabilities through a bespoke commercial package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Explore the Agenda
Discover the latest breakthroughs in PROTACs, molecular glues, and proximity therapeutics through expert-led sessions and case studies.
Partner With Us
Connect with Europe's leading drug developers seeking discovery platforms, chemistry services, and translational support for TPD programs.
Join the TPD Community
Network with top scientists and biopharma innovators driving proximity-based drug development across oncology, CNS, and beyond.